US · INBS
Intelligent Bio Solutions Inc.
- Sector
- Healthcare · Medical - Diagnostics & Research
- Headquarters
- New York City, NY 10019
- Website
- gbs.inc
Price · as of 2025-06-30
$2.41
Market cap 2.91M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $6.20 | +157.26% |
| Intrinsic Value(DCF) | $609.02 | +25,170.54% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $8,112.00 | $20,242.22 | $490.01 | $0.00 | $0.00 |
| 2022 | $1,231.20 | $12,374.80 | |||
| 2023 | $193.20 | $0.00 | $0.00 | ||
| 2024 | $15.80 | $58.48 | $2,442,270.45 | $0.00 | $0.00 |
| 2025 | $15.50 | $6.20 | $233.75 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Intelligent Bio Solutions Inc.'s (INBS) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $6.20
- Current price
- $2.41
- AI upside
- +157.26%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$609.02
+25,170.54% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| INBS | Intelligent Bio Solutions… | $2.41 | 2.91M | +157% | +25,171% | — | — | -0.77 | 2.73 | 2.68 | -0.79 | — | -10.29 | 40.85% | -348.71% | -346.23% | -187.27% | -392.10% | -96.28% | 0.09 | -174.82 | 0.77 | 0.49 | 0.08 | -6865.00% | -190.00% | 119.00% | -121.23% | -1.81 | -365.01% | 0.00% | 0.00% | 0.00% | -0.70 | -0.75 | 2.44 | -13.77 |
| ADIL | Adial Pharmaceuticals, In… | $2.53 | 2.43M | — | — | — | — | -1.06 | 3.43 | — | -1.23 | — | 3.43 | 0.00% | — | — | -323.80% | -1052.66% | -269.86% | 0.00 | — | 4.16 | 3.84 | 0.45 | -8695.00% | — | — | -49.65% | -7.09 | -879.58% | 0.00% | 0.00% | 6.62% | -1.23 | -1.47 | — | -18.87 |
| BNGO | Bionano Genomics, Inc. | $1.15 | 3.78M | +6,408% | +42% | — | +30,750% | -0.07 | 0.22 | 0.25 | -0.26 | — | 0.30 | 1.23% | -337.87% | -363.98% | -170.33% | -128.38% | -76.97% | 0.77 | -359.80 | 1.06 | 0.38 | -0.19 | -9964.00% | -1479.00% | -4559.00% | -889.15% | -1.85 | -85.22% | 0.00% | 0.00% | 558.30% | -0.25 | -0.37 | 0.83 | -16.59 |
| CHEK | Check-Cap Ltd. | $1.68 | 9.83M | — | — | — | — | -0.19 | -3.24 | — | -0.49 | -0.43 | -3.24 | 0.00% | — | — | -226.19% | 1959.89% | -198.07% | -0.09 | -2883.22 | 0.15 | 0.15 | -0.01 | 4333.00% | — | -9995.00% | -0.17% | 0.00 | 0.60% | 0.00% | 0.00% | 0.00% | -0.18 | -570.68 | — | -861.86 |
| HSCS | HeartSciences Inc. | $2.79 | 6.25M | +699% | -40% | — | +21,742% | -0.45 | 19.02 | 897.28 | -0.71 | — | -2.77 | -2884.71% | -192013.13% | -201499.52% | -233.04% | -360.16% | -127.72% | 14.55 | -16.69 | 0.59 | 0.30 | -0.23 | -5016.00% | -7661.00% | 2014.00% | -190.70% | -2.00 | -320.95% | 0.00% | 0.00% | 0.00% | -0.69 | -0.78 | 1331.10 | -31.62 |
| MYNZ | Mainz Biomed B.V. | $0.76 | 3.11M | +29,917% | +195% | — | — | -0.25 | 0.90 | 6.08 | -0.13 | -0.02 | 1.79 | 64.31% | -2091.23% | -2421.80% | -465.82% | -559.63% | -151.15% | 0.54 | -17.39 | 1.32 | 1.08 | 0.15 | 128025.00% | -17.00% | -2724.00% | -319.32% | -2.87 | -519.21% | 0.00% | 0.00% | 61.01% | -0.13 | -0.14 | 2.76 | -13.59 |
| PAVM | PAVmed Inc. | $10.08 | 5.41M | +10,627% | +918% | +5,945% | +35,854% | 0.23 | -2.66 | 2.21 | 1.26 | — | -2.66 | -101.60% | -1485.38% | 1328.58% | -100.94% | -2590.22% | 89.14% | -12.77 | -988.60 | 0.06 | 0.03 | 1.03 | -10541.00% | 2215.00% | -3571.00% | -507.27% | -0.95 | -1956.86% | 0.00% | 0.00% | 0.00% | -0.84 | -1.11 | 12.45 | -17.53 |
| POAI | Predictive Oncology Inc. | $1.87 | 1.36M | +2,229% | +265% | — | -66% | -8.59 | -460.28 | 57.43 | -9.24 | — | -225.96 | 49.12% | -673.69% | -751.39% | -269.18% | -631.77% | -112.02% | -10.52 | — | 0.62 | 0.41 | -0.14 | -3563.00% | -878.00% | -1859.00% | -11.78% | -3.05 | -634.35% | 0.00% | 0.00% | 0.00% | -8.65 | -8.62 | 58.29 | -47.25 |
| SSKN | STRATA Skin Sciences, Inc… | $0.21 | 892.55K | +26,438% | +386% | — | — | -9.66 | 19.60 | 2.90 | -37.52 | — | -32.12 | 56.85% | -27.58% | -30.05% | -114.22% | -51.01% | -25.80% | 3.31 | -4.39 | 1.13 | 0.86 | -3.23 | -1613.00% | 61.00% | -7385.00% | -1.49% | 0.01 | -8.11% | 0.00% | 0.00% | 0.00% | -11.52 | -73.65 | 3.18 | -7.58 |
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
- CEO
- Harry Simeonidis
- Employees
- 50
- Beta
- 4.51
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($609.02 ÷ $2.41) − 1 = +25,170.54% (DCF, example).